The BIO Protocol is actually a financial platform that helps science become more decentralized. Its goal is to allow more capital and talent to enter the field of on-chain science and promote the development of biotechnology and scientific research. In short, it creates an efficient scientific ecosystem through the commercialization of funds, liquidity and intellectual property.
What is the goal of the BIO protocol?
Curation and creation: It is to help the newly born biological DAO (decentralized autonomous organization) obtain funds and develop rapidly.
Liquidity support: Ensure that these DAOs and related biotech assets always have capital flow and everyone can buy and sell them.
Standardization construction: By providing standardized frameworks, token economics, data tools, etc., the entire BioDAO ecosystem will be clearer and more orderly.
Intellectual Property Commercialization: Make innovative intellectual property and data in the scientific field tradable, helping them enter the market faster.
How does the core operating mechanism work?
Curation (BIO Staking): If you hold BIO tokens, you can participate in selecting which new BioDAOs can join the protocol by locking tokens (generating vBIO). If you select a DAO and it is approved by the community, you can participate in its funding rounds and enjoy some exclusive resources. In this way, your interests are tied to the interests of the entire network. It's quite interesting.
Funding: If the DAO you vote for is accepted, all supporters can participate in its initial financing. In other words, you can help promising scientific projects get funding from the beginning on the same terms as institutional investors.
Liquidity management: BioDAO focuses on scientific research and does not need to worry about so many liquidity issues. Therefore, the BIO protocol will help manage their secondary market liquidity and ensure that these DAOs can convert tokens and other assets into cash or other assets at a low cost. In short, it is to make money flow and not get stuck.
Reward mechanism (bio/cumulative rewards): The BIO protocol will reward BioDAOs that achieve important goals, allowing them to continue to promote the progress of scientific research. For example, if a DAO completes on-chain scientific funding, increases token liquidity, or promotes scientific results into clinical trials, there will be rewards. People who hold BIO can also participate in this reward pool and get additional benefits.
Meta-Governance: The BIO protocol holds tokens of multiple BioDAOs, so it can serve as a governance layer, allowing BIO holders to participate in the decision-making of managing these DAOs and scientific assets. In other words, you are not only an investor, but also a governor!
How does the BIO protocol accumulate value?
Token distribution: When each BioDAO is incubated, the BIO protocol will provide a grant of $100,000 in exchange for 6.9% of the DAO's tokens. As these DAOs become more valuable, the assets of the BIO protocol will also increase in value. Just like investing in the stock market, investing in early projects and waiting for them to rise will make you more money.
Protocol Liquidity (POL): The BIO protocol earns fees and income from asset appreciation by managing the liquidity pool. These incomes will be used to support more BioDAO projects, forming a positive cycle and making the entire ecosystem stronger and stronger. In short, the money earned by the protocol will also turn into more opportunities to drive the growth of the entire ecosystem.
Circuit Diagram
2021
July: VitaDAO launched
VitaDAO is the first community-driven decentralized biotechnology organization (BioDAO) focused on promoting biological research and innovation. The launch of VitaDAO marks the beginning of the BIO protocol's funding and support for decentralized science, opening a new chapter in on-chain biotechnology research.August: Collaboration with the University of Copenhagen to fund the first on-chain science project
The BIO Protocol has partnered with the University of Copenhagen to fund and advance the first scientific project supported by on-chain funds. This is an important milestone for the BIO Protocol to promote decentralized science and lays the foundation for funding more scientific projects in the future.
2022
December: Pfizer Ventures backs VitaDAO with $4.1 million
Pfizer Ventures, a world-renowned pharmaceutical company, has invested $4.1 million in VitaDAO, demonstrating the importance that traditional capital markets attach to decentralized science and biotechnology. This investment supports the further development of VitaDAO and the BIO Protocol in the global biotechnology field.
2023
June: Newcastle University launches first IP-Token
Newcastle University has launched the first scientific intellectual property token (IP-Token), marking the beginning of decentralized scientific property transactions. The BIO Protocol provides a platform for academic institutions to combine blockchain technology and promote the tokenization of intellectual property.November: BioDAO token market value exceeds $200 million
This breakthrough moment demonstrates that the economic scale of the BIO protocol and its ecosystem is growing rapidly, with the market value of the BioDAO token exceeding $200 million, becoming a key asset in the decentralized science field.December: HairDAO becomes the first DAO to apply for a scientific patent
HairDAO became the first decentralized autonomous organization (DAO) to apply for a scientific patent from the Patent Office. This event marks that decentralized science is not limited to the research stage, but has expanded to the level of commercialization and intellectual property protection, pushing the forefront of decentralized scientific innovation.
2024
November: Binance Labs makes first DeSci investment in BIO Protocol
Binance Labs, the world’s leading cryptocurrency investment firm, makes its first DeSci (decentralized science) investment in BIO Protocol, demonstrating that cryptocurrency and blockchain technology are becoming an important source of capital for the biotechnology sector.November: BIO Genesis raises over $33 million
BIO Genesis has successfully raised more than $33 million in funding, providing strong financial support for the future development of the protocol. The funds will be used to accelerate the incubation of new bioDAOs, funding of scientific projects, and expansion of the ecosystem.
2025
Q1: BIO Protocol Launchpad goes live
BIO Protocol Launchpad will be launched in the first quarter of 2025, providing a platform to support the launch of new bio-DAOs and promote the incubation of decentralized scientific projects. Through Launchpad, more potential scientific projects will be funded and promoted.
Q1: BIO Research Agent
The BIO Protocol will launch a research agent in the first quarter of 2025 to further promote the scale and marketization of on-chain scientific research. This agent will help new scientific research projects find funding support while also ensuring that research results can be transformed into commercial products in a timely manner.2025: BIO as BioDAO brings hundreds of new patient communities on-chain
By 2025, the BIO Protocol is expected to support hundreds of new patient communities on the chain. These communities will be closely integrated with biotech research and innovation to jointly promote the development of decentralized medicine and biotechnology.
Overall
The BIO protocol forms the financial foundation of decentralized science through five core functions: curation, funding support, liquidity management, reward incentives, and meta-governance. It not only provides financial support to the scientific community, but also promotes the commercialization and liquidity development of scientific IP, enabling efficient integration of capital and technology. BIO is defining new standards for the decentralized scientific economy and providing strong momentum for innovation in global biotechnology.